All terms in HP

Label Id Description
positive regulation of natural killer cell mediated immunity GO_0002717 [Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated immunity.]
positive regulation of innate immune response GO_0045089 [Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.]
positive regulation of lymphocyte mediated immunity GO_0002708 [Any process that activates or increases the frequency, rate, or extent of lymphocyte mediated immunity.]
regulation of natural killer cell mediated immunity GO_0002715 [Any process that modulates the frequency, rate, or extent of natural killer cell mediated immunity.]
negative regulation of natural killer cell mediated immunity GO_0002716 [Any process that stops, prevents, or reduces the frequency, rate, or extent of natural killer cell mediated immunity.]
negative regulation of lymphocyte mediated immunity GO_0002707 [Any process that stops, prevents, or reduces the frequency, rate, or extent of lymphocyte mediated immunity.]
negative regulation of innate immune response GO_0045824 [Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.]
regulation of innate immune response GO_0045088 [Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection.]
regulation of lymphocyte mediated immunity GO_0002706 [Any process that modulates the frequency, rate, or extent of lymphocyte mediated immunity.]
N-nicotinoylglycine CHEBI_7563 [An N-acylglycine having nicotinoyl as the acyl substituent.]
Disseminated nontuberculous mycobacterial infection HP_0032283 [An infection with nontuberculous mycobacteria that affects multiple body sites. Such infections can occur in individuals with immune disease.]
positive regulation of T cell mediated immunity GO_0002711 [Any process that activates or increases the frequency, rate, or extent of T cell mediated immunity.]
regulation of T cell mediated immunity GO_0002709 [Any process that modulates the frequency, rate, or extent of T cell mediated immunity.]
Contact dermatitis HP_0032282 [An inflammatory process in skin caused by an exogenous agent that directly or indirectly injure the skin. If the offending agent is identified and removed, the eruption will resolve. An unusual or patterned eruption may be a clue to the presence of a contact dermatitis. Patch testing may be helpful in the differential diagnosis.]
negative regulation of T cell mediated immunity GO_0002710 [Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell mediated immunity.]
Abnormal base excess HP_0032281 [Deviation from the normal quantity of base excess, defined as the amount of strong acid (in millimoles per liter) that needs to be added in vitro to 1 liter of fully oxygenated whole blood to return a blood sample to standard conditions (pH of 7.40, Pco2 of 40 mm Hg, and temperature of 37 degrees C).]
Oligoclonal elevation of circulating IgG HP_0032289 [An increase in circulating immunoglobulins characterized by two or more bands in serum electrophoresis but not the broad diffuse band that characterizes a polyclonal increase in circulating immunoglobulins.]
Increased circulating IgG concentration HP_0003237 [An abnormally increased level of immunoglobulin G in blood.]
Polyclonal elevation of circulating IgG HP_0032288 [An increase in polyclonal immunoglobulins resulting from many different plasma cells. On serum electrophoresis, a polyclonal gammopathy is characterized by a broad diffuse band with one or more heavy chains and kappa and lambda light chains.]
Ultra-low vision with no light perception HP_0032287 [Ultra-low vision with complete lack of light and form perception.]